Samsung Biologics showcases CDMO capabilities in Singapore

Samsung Biologics has highlighted its contract development and manufacturing organization, or CDMO, capabilities at Biologics Manufacturing Asia 2026 in Singapore, receiving a bioprocessing excellence award during the two-day event. According to Samsung Biologics on Thursday, the Korean CDMO leader presented its top-notch CDO technologies and services at the conference on Wednesday. Lim Heon-chang, director of formulation development at Samsung Biologics’ CDO division, introduced case studies of

March 12, 2026

[팟캐스트] (774) 텔레그램 타고 번진 ‘보복 대행’

진행자: 간형우, Devin Whiting Revenge for hire spreads via Telegram 기사 요약: 텔레그램을 통해 돈을 받고 타인의 집을 훼손하는 등 ‘보복 대행’ 범죄가 잇따라 발생하자 경찰이 관련 수사를 확대하고 있다. [1] Concerns are growing over a recent string of so-called “revenge for hire” crimes, most of which involve the vandalism of apartment doors. string: 끈, 일련 vandalism: 기물 파손 행위 [2] A man in his 20s was recently taken into custody on suspicion of property damage after smearing waste and paint on a stranger’s apartment door for money, news reports said Monday. c

March 12, 2026

NCSoft to acquire German mobile game company JustPlay

NCSoft said Wednesday it is investing $202 million in JustPlay, a German-based mobile game platform company, to acquire a 70 percent stake, looking to speed up its plan to expand the global mobile casual game business. According to NCSoft, the board of directors approved the acquisition on the previous day. The Korean game company expects to complete the acquisition by the end of next month. JustPlay, an advertisement technology-based mobile casual game developer and reward platform company, was

March 11, 2026

Samsung Biologics, Eli Lilly to build biotech innovation hub in Korea

Samsung Biologics has teamed up with Eli Lilly to set up an open innovation hub for emerging biotechnology companies in Korea, marking the first time for Eli Lilly to establish such a site outside the United States and China. According to Samsung Biologics on Tuesday, the two companies agreed to build a Lilly Gateway Labs site within the Korean contract development and manufacturing organization, or CDMO, leader’s second bio campus in Songdo, Incheon. The LGL facility will consist of five storie

March 11, 2026

US investors drop Section 301 petition over Coupang probe

Two US investors in Coupang — Greenoaks and Altimeter — have withdrawn their petition urging the United States Trade Representative to investigate the South Korean government’s handling of the e-commerce platform following a massive data breach in November last year. The investors filed the petition in January under Section 301 of the US Trade Act of 1974, a law used to address unfair trade practices by foreign governments. “Over the last several weeks, we have had constructive discussions with

March 10, 2026

Pablo Air aims higher with AI drone swarms

For Kim Young-joon, the 36-year-old founder and chair of Pablo Air, volunteering for South Korea’s Army special forces was an easy decision. “I don’t really like doing what others usually do,” Kim said in an interview with The Korea Herald at the company’s office in Incheon last week. While Korean men typically complete their mandatory military service through conscription, Kim chose the more demanding route of volunteering as an officer in the special forces. “I like adventures, so I was lookin

March 9, 2026

Shin Yoo-yeol steps into spotlight as Lotte’s biotech bet tests heir

The message from Chairman Shin Dong-bin at the start of this year was blunt and poignant: Lotte Group cannot preserve its empire without shedding old habits. That mandate for renewed innovation and tighter capital discipline now seems to fall squarely on his eldest son, Shin Yoo-yeol, at the helm of the group’s future-growth agenda. Just three months after the 39-year-old took charge of Lotte Biologics, the conglomerate’s contract development and manufacturing arm, expectations are gathering aro

March 8, 2026

Iran war puts Korean drugmakers on edge

Unease centered around the Iran war is keeping Korean drugmakers and health device companies on their toes amid growing concerns over supply chains and exports. The Korea Pharmaceutical and Bio-Pharma Manufacturers Association has warned that product supply schedules could be disrupted if the conflict in the Middle East leads to reduced flights, altered flight routes or closed airways. Delayed payments could also pose risks for companies, the business lobby said. “Disposable culture bags, filter

March 8, 2026

Daewoo E&C selected as sole bidder for W10.7tr airport project

Daewoo Engineering & Construction said Thursday it has been selected as the sole negotiating partner for the land reclamation project for the Gadeokdo New Airport in Busan, marking a key step toward advancing one of Korea’s largest infrastructure development projects. According to Daewoo E&C, it officially notified the Public Procurement Service of its intention to proceed with a negotiated contract for the project the previous day. The procurement agency had earlier informed the company that it

March 5, 2026

Korean Air chief calls for unity as Asiana merger nears

Hanjin Group Chair Walter Cho has reiterated the historic importance of ushering a new era for Korean Air as South Korea’s largest air carrier gears up for the merger with the country’s second-largest carrier, Asiana. “As I pledged when announcing the acquisition of Asiana Airlines, I will complete the historic task of reorganizing Korea’s aviation industry and creating a stronger aviation ecosystem,” Cho said in a speech during Korean Air’s 57th anniversary ceremony on Tuesday. “For an integrat

March 4, 2026